FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis
Authors:
Open Access
- 21 January 2010
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 136 (7) , 1007-1022
Abstract
Background and purpose Breast carcinoma is the most common cancer in female patients with a propensity for recurrence and metastases. The accuracy of ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), scintimammography (SMM) and positron emission tomography (PET) in diagnosing the recurrent and/or breast cancer has never been systematically assessed, and present systematic review was aimed at this issue. Methods MEDLINE and EMBASE were searched for articles dealt with detection of recurrent and/or metastatic breast cancer by US, CT, MRI, SMM or PET whether interpreted with or without the use of CT. Histopathologic analysis and/or close clinical and imaging follow-up for at least 6 months were used as golden reference. We extracted data to calculate sensitivity, specificity, summary receiver operating characteristic curves and area under the curve and to test for heterogeneity. Result In 42 included studies, US and MRI had highest pooled specificity (0.962 and 0.929, respectively); MRI and PET had highest pooled sensitivity (0.9500 and 0.9530, respectively). The AUC of US, CT, MRI, SMM and PET was 0.9251, 0.8596, 0.9718, 0.9386 and 0.9604, respectively. Results of pairwise comparison between each modality demonstrated that AUC of MRI and PET was higher than that of US or CT, p < 0.05. No statistical significance was found between MRI and PET. There was heterogeneity among studies and evidence of publication bias. Conclusion In conclusion, MRI seemed to be a more useful supplement to current surveillance techniques to assess patients with suspected recurrent and/or metastatic breast cancer. If MRI shows an indeterminate or benign lesion or MRI was not applicable, FDG-PET could be performed in addition.Keywords
This publication has 90 references indexed in Scilit:
- Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammographyNuclear Medicine Communications, 2007
- Recurrent Disease after Breast Preserving Therapy (BPT) and Radiation Therapy for Breast Cancer - Diagnostic Yield of Palpation, Mammography and UltrasonographyUltraschall in der Medizin - European Journal of Ultrasound, 2007
- An overview of prognostic factors for long-term survivors of breast cancerBreast Cancer Research and Treatment, 2007
- Computed tomography in suspected local breast cancer recurrenceBreast Cancer Research and Treatment, 2006
- A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastasesBreast Cancer Research and Treatment, 2005
- Clinical Utility of 99m Tc-Sestamibi Scintimammography in the Management of Equivocal Breast LesionsCancer Biotherapy and Radiopharmaceuticals, 2004
- Impact of FDG PET on Defining the Extent of Disease and on the Treatment of Patients with Recurrent or Metastatic Breast CancerAmerican Journal of Roentgenology, 2004
- Prediction of the long‐term survival in breast cancer patients according to the present oncological statusStatistics in Medicine, 2002
- Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrenceBritish Journal of Surgery, 1999
- Metastatic pattern in recurrent breast cancer: Special reference to intrathoracic recurrencesCancer, 1988